CA3045703C - Piperidine-2,6-dione derivatives and ulcerative colitis treating - Google Patents
Piperidine-2,6-dione derivatives and ulcerative colitis treating Download PDFInfo
- Publication number
- CA3045703C CA3045703C CA3045703A CA3045703A CA3045703C CA 3045703 C CA3045703 C CA 3045703C CA 3045703 A CA3045703 A CA 3045703A CA 3045703 A CA3045703 A CA 3045703A CA 3045703 C CA3045703 C CA 3045703C
- Authority
- CA
- Canada
- Prior art keywords
- dione
- pharmaceutically acceptable
- acceptable salts
- dioxopiperidin
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611041317.5 | 2016-11-24 | ||
| CN201611041317 | 2016-11-24 | ||
| PCT/CN2017/112668 WO2018095377A1 (zh) | 2016-11-24 | 2017-11-23 | 哌啶-2,6-二酮衍生物以及溃疡性结肠炎的治疗 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3045703A1 CA3045703A1 (en) | 2018-05-31 |
| CA3045703C true CA3045703C (en) | 2021-11-02 |
Family
ID=62194806
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3045703A Active CA3045703C (en) | 2016-11-24 | 2017-11-23 | Piperidine-2,6-dione derivatives and ulcerative colitis treating |
| CA3049161A Active CA3049161C (en) | 2016-11-24 | 2017-11-23 | Piperidine-2,6-dione derivatives and crohn's disease treating |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3049161A Active CA3049161C (en) | 2016-11-24 | 2017-11-23 | Piperidine-2,6-dione derivatives and crohn's disease treating |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US11485724B2 (https=) |
| EP (2) | EP3546450A4 (https=) |
| JP (2) | JP7143295B2 (https=) |
| CN (2) | CN108101887A (https=) |
| AU (2) | AU2017366515B2 (https=) |
| CA (2) | CA3045703C (https=) |
| WO (2) | WO2018095377A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017366515B2 (en) | 2016-11-24 | 2021-01-21 | Ganzhou Hemay Pharmaceutical, Co., Ltd | Piperidine-2,6-diketone derivative and treatment for Crohn's disease |
| CN108727319A (zh) * | 2018-09-05 | 2018-11-02 | 常州大学 | 一种3-硝基邻苯二甲酸酐的制备方法 |
| CN109293631B (zh) * | 2018-11-30 | 2020-05-08 | 常州制药厂有限公司 | 3-氨基-n-(2，6-二氧代-3-哌啶基)-邻苯二甲酰亚胺化合物的制备方法 |
| GB202002926D0 (en) * | 2020-02-28 | 2020-04-15 | Benevolentai Tech Limited | Compositions and uses thereof |
| CN111320604B (zh) * | 2020-04-22 | 2021-02-09 | 牡丹江医学院 | 一种治疗小儿口腔黏膜疾病的化合物、制备方法及其用途 |
| CN118370746A (zh) * | 2024-04-25 | 2024-07-23 | 江苏省中医院 | 马尿酸在制备溃疡性结肠炎治疗药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2172474B1 (es) * | 2001-03-01 | 2004-01-16 | Fundacion Universitaria San Pa | Derivados de glutarimida como agentes terapeuticos. |
| EP1336602A1 (en) * | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
| CN100488959C (zh) | 2003-03-27 | 2009-05-20 | 天津和美生物技术有限公司 | 水溶性的酞胺哌啶酮衍生物 |
| CN1867331B (zh) * | 2003-09-17 | 2010-05-26 | 美国政府健康及人类服务部 | 作为TNF-α调节剂的沙利度胺类似物 |
| JP2008528514A (ja) * | 2005-01-25 | 2008-07-31 | セルジーン・コーポレーション | ４−アミノ−２−（３−メチル−２，６−ジオキソピペリジン−３−イル）−イソインドール−１，３−ジオンを使用する方法及び組成物 |
| CN100383139C (zh) * | 2005-04-07 | 2008-04-23 | 天津和美生物技术有限公司 | 可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物 |
| CN1961876A (zh) * | 2005-11-08 | 2007-05-16 | 北京恩华医药研究院 | 邻苯二甲酰亚胺衍生物在制备抗新血管生成的药物中的用途 |
| ES2664872T3 (es) | 2010-06-18 | 2018-04-23 | Taiho Pharmaceutical Co., Ltd | Moduladores PRPK-TPRKB y sus usos |
| CN105246480A (zh) | 2013-04-02 | 2016-01-13 | 细胞基因公司 | 使用4-氨基-2-(2,6-二氧代-哌啶-3-基)-异吲哚啉-1,3-二酮治疗和控制中枢神经系统癌症的方法和组合物 |
| AU2017366515B2 (en) | 2016-11-24 | 2021-01-21 | Ganzhou Hemay Pharmaceutical, Co., Ltd | Piperidine-2,6-diketone derivative and treatment for Crohn's disease |
-
2017
- 2017-11-23 AU AU2017366515A patent/AU2017366515B2/en active Active
- 2017-11-23 US US16/464,224 patent/US11485724B2/en active Active
- 2017-11-23 EP EP17874499.1A patent/EP3546450A4/en active Pending
- 2017-11-23 CA CA3045703A patent/CA3045703C/en active Active
- 2017-11-23 CA CA3049161A patent/CA3049161C/en active Active
- 2017-11-23 AU AU2017366514A patent/AU2017366514B2/en active Active
- 2017-11-23 WO PCT/CN2017/112668 patent/WO2018095377A1/zh not_active Ceased
- 2017-11-23 WO PCT/CN2017/112669 patent/WO2018095378A1/zh not_active Ceased
- 2017-11-23 CN CN201711185728.6A patent/CN108101887A/zh active Pending
- 2017-11-23 EP EP17873820.9A patent/EP3546449A4/en active Pending
- 2017-11-23 JP JP2019528110A patent/JP7143295B2/ja active Active
- 2017-11-23 US US16/464,228 patent/US20220372013A2/en active Pending
- 2017-11-23 CN CN201711184758.5A patent/CN108101886A/zh active Pending
- 2017-11-23 JP JP2019528114A patent/JP7143296B2/ja active Active
-
2022
- 2022-06-03 US US17/832,518 patent/US11873287B2/en active Active
-
2023
- 2023-12-08 US US18/533,755 patent/US12331030B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US12331030B2 (en) | 2025-06-17 |
| JP2020500205A (ja) | 2020-01-09 |
| US20220306600A1 (en) | 2022-09-29 |
| CA3049161C (en) | 2023-03-07 |
| US20240132466A1 (en) | 2024-04-25 |
| US11485724B2 (en) | 2022-11-01 |
| CA3045703A1 (en) | 2018-05-31 |
| JP7143296B2 (ja) | 2022-09-28 |
| WO2018095377A1 (zh) | 2018-05-31 |
| AU2017366515A1 (en) | 2019-06-13 |
| US20190389835A1 (en) | 2019-12-26 |
| EP3546449A4 (en) | 2020-06-10 |
| AU2017366515B2 (en) | 2021-01-21 |
| CA3049161A1 (en) | 2018-05-31 |
| JP7143295B2 (ja) | 2022-09-28 |
| EP3546450A1 (en) | 2019-10-02 |
| US20220372013A2 (en) | 2022-11-24 |
| AU2017366514B2 (en) | 2021-01-21 |
| CN108101887A (zh) | 2018-06-01 |
| WO2018095378A1 (zh) | 2018-05-31 |
| US20190352277A1 (en) | 2019-11-21 |
| JP2020500204A (ja) | 2020-01-09 |
| CN108101886A (zh) | 2018-06-01 |
| AU2017366514A1 (en) | 2019-06-13 |
| EP3546450A4 (en) | 2020-06-10 |
| US11873287B2 (en) | 2024-01-16 |
| EP3546449A1 (en) | 2019-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12331030B2 (en) | Piperidine-2,6-dione derivatives and ulcerative colitis treating | |
| CN111662281B (zh) | 水杨酸类小檗碱型生物碱季铵盐及其制备药物的用途 | |
| KR20080017339A (ko) | 엘에프엠에이유 및 엘디티를 사용하여 암 및 다른 증상또는 질환을 치료하는 방법 | |
| ES2509143T3 (es) | Tratamiento de una septicemia con 5-etil-1-fenil-2(1H)-piridona | |
| JPH08503699A (ja) | 全身性炎症と炎症性肝炎の治療のためのピリミジンヌクレオチド前駆体 | |
| WO2014129513A1 (ja) | 潰瘍性大腸炎の予防または治療剤と新規フラーレン誘導体 | |
| JP2010534709A (ja) | ９−デオキソ−９ａ−メチル−９ａ−アザ−９ａ−ホモエリスロマイシンＡ誘導体およびマラリアを治療するためのそれらの使用 | |
| CN1989090B (zh) | 顺式-1,2-取代的二苯乙烯衍生物及其用于制备治疗和/或预防糖尿病的药物的用途 | |
| WO2017113489A1 (zh) | 巨大戟二萜醇类化合物及其在抗hiv潜伏治疗上的应用 | |
| CN107619428B (zh) | 鸟氨酸与门冬氨酸二肽化合物的酰化衍生物及其应用 | |
| WO2004080453A1 (ja) | 抗ｃ型肝炎ウイルス剤と抗ｈｉｖ剤 | |
| JP2009535395A (ja) | ９ａ−置換アザリド | |
| JP4601309B2 (ja) | 抗ｃ型肝炎ウイルス剤と抗ｈｉｖ剤 | |
| CN106265677B (zh) | 一种防治溃疡性结肠炎的药物组合物及其应用 | |
| WO2024125581A2 (zh) | 化合物及其用途 | |
| WO2024002112A1 (zh) | 一种治疗猫冠状或杯状病毒感染的方法 | |
| CN121735956A (zh) | 一种病毒nsp12蛋白降解剂及其制备方法和应用 | |
| WO2019160926A1 (en) | Compounds comprising short-chain fatty acid moieties and compositions and methods thereof | |
| US20160326098A1 (en) | Pharmaceutically Active Compound for Use as Anti-inflammatory Agent | |
| CN1330922A (zh) | 用于治疗或预防与免疫缺损病毒和逆转录病毒有关之疾病的药物组合物及组合 | |
| JP2002020283A (ja) | Ｈｉｖおよびレトロウイルスに関連する障害の処置または予防のための薬学的組成物および組み合わせ | |
| HK1065253A (en) | Use of glycyrrhizin and its derivatives as rantes inducers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190523 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 7TH ANNIV.) - SMALL Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241111 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241111 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 8TH ANNIV.) - SMALL Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251110 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251110 |